Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CTLT | Catalent, Inc. | -0.95% | 84.06 | 2.1% | $220.68m | |
| JAZZ | Jazz Pharmaceuticals Plc | -3.24% | 137.31 | 2.4% | $157.47m | |
| HZNP | Horizon Therapeutics Plc | -1.65% | 78.61 | 5.8% | $149.95m | |
| SAVA | Cassava Sciences, Inc. | -8.64% | 9.20 | 0.0% | $148.70m | |
| CORT | Corcept Therapeutics, Inc. | -2.61% | 17.52 | 5.5% | $122.70m | |
| VRX | Valeant Pharmaceuticals International, Inc. | -3.99% | 16.51 | 14.1% | $97.15m | |
| BHC | Bausch Health Cos., Inc. | -3.99% | 16.51 | 0.0% | $68.41m | |
| AMRN | Amarin Corp. Plc | -3.00% | 4.05 | 1.5% | $55.09m | |
| MYOK | MyoKardia, Inc. | -8.65% | 124.75 | 1.8% | $52.71m | |
| ARGX | argenx SE | -2.82% | 242.71 | 0.0% | $52.02m | |
| SAGE | SAGE Therapeutics, Inc. | -4.26% | 59.79 | 8.6% | $44.46m | |
| GWPH | GW Pharmaceuticals Plc | -0.25% | 99.93 | 6.2% | $40.64m | |
| AXSM | Axsome Therapeutics, Inc. | -2.74% | 79.41 | 1.9% | $37.95m | |
| MRNS | Marinus Pharmaceuticals, Inc. | -3.89% | 3.33 | 1.9% | $37.19m | |
| PRGO | Perrigo Co. Plc | -3.27% | 45.53 | 6.8% | $34.73m |
Company Profile
VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm’s products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and is headquartered in Campbell, CA.